0001127602-12-026742.txt : 20120920
0001127602-12-026742.hdr.sgml : 20120920
20120920123253
ACCESSION NUMBER: 0001127602-12-026742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120919
FILED AS OF DATE: 20120920
DATE AS OF CHANGE: 20120920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BERSTEIN DAVID L
CENTRAL INDEX KEY: 0001242986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21696
FILM NUMBER: 121101520
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000884731
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223106987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6174940400
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-09-19
0000884731
ARIAD PHARMACEUTICALS INC
ARIA
0001242986
BERSTEIN DAVID L
C/O ARIAD PHARMACEUTICALS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
MA
02139
1
Senior VP, Chief IP Officer
Common Stock
2012-09-19
4
M
0
11375
5.23
A
201231
D
Common Stock
2012-09-19
4
S
0
11375
24.00
D
189856
D
Common Stock
2012-09-19
4
S
0
8000
24.00
D
181856
D
Employee Stock Option (Right to Buy)
5.23
2012-09-19
4
M
0
11375
0
D
2006-09-09
2014-09-09
Common Stock
11375
7825
D
Shares were aquired upon the exercise of outstanding stock options at $5.23 per share.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2012.
/s/Edward M. Fitzgerald, Attorney-in-Fact
2012-09-20